Nephros INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ

16 Sept 2026

NEPH

SCHEDULE: Nephros Inc. Ownership Update Filed

Charles E. Davidson and CD Holding Company, LLC have jointly filed a Schedule 13G, reporting beneficial ownership of 5.68% of Nephros, Inc. common stock.

NASDAQ

14 Nov 2025

NEPH

Nephros INC

SCHEDULE: Topline Capital Discloses 5.6% Stake in Nephros Inc.

Topline Capital Management, LLC, Collin McBirney, and Topline Capital Partners, LP have disclosed a 5.6% beneficial ownership stake in Nephros Inc. common stock.